Adma Biologics, Inc.
ADMA· Nasdaq
Released Aug 11, 2017, after the close
10-Q filed Aug 11, 2017, 42 days after period end · 0001193805-17-001446
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $3.40M | $2.27M | $1.31M | $1.50M |
| Net Income | -$9.04M | -$6.01M | -$4.68M | -$3.96M |
| EPS Diluted | -$0.55 |
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
| -$0.50 |
| -$0.44 |
| -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.